Trinity Biotech plc (TRIB)
NASDAQ: TRIB · IEX Real-Time Price · USD
2.860
-0.090 (-3.05%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Trinity Biotech Revenue
Trinity Biotech had revenue of $14.70M in the quarter ending March 31, 2024, a decrease of -0.84%. This brings the company's revenue in the last twelve months to $56.71M, down -23.30% year-over-year. In the year 2023, Trinity Biotech had annual revenue of $56.83M, down -9.10%.
Revenue (ttm)
$56.71M
Revenue Growth
-23.30%
P/S Ratio
0.39
Revenue / Employee
$149,229
Employees
380
Market Cap
21.85M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 56.83M | -5.69M | -9.10% |
Dec 31, 2022 | 62.52M | -18.63M | -22.96% |
Dec 31, 2021 | 81.15M | -20.83M | -20.43% |
Dec 31, 2020 | 101.98M | 11.55M | 12.77% |
Dec 31, 2019 | 90.44M | -6.60M | -6.80% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Meihua International Medical Technologies Co. | 97.10M |
Nephros | 14.06M |
Femasys | 1.05M |
Can-Fite BioPharma | 743.00K |
Biora Therapeutics | 544.00K |
TRIB News
- 17 days ago - Trinity Biotech Announces Appointment of A New CFO - GlobeNewsWire
- 4 weeks ago - Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor - GlobeNewsWire
- 6 weeks ago - Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association - GlobeNewsWire
- 7 weeks ago - Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology - GlobeNewsWire
- 2 months ago - Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance - GlobeNewsWire
- 2 months ago - Trinity Biotech plc to Announce Q1 2024 Financial Results - GlobeNewsWire
- 2 months ago - Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI - GlobeNewsWire
- 2 months ago - Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales - GlobeNewsWire